Physician
Dermatology
Dr. Karl R. Beutner, MD
|
|
Give Review
Karl R. Beutner, MD is an expert in the field of Dermatology. He studied medicine at University at Buffalo, School of Medicine and Biomedical Sciences. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Karl R. Beutner is a published doctor and has 70 publications published. The lastest was: 'External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts.' Karl Beutner accepts Medicare.
Publications
- Guidelines of care for the management of primary cutaneous Melanoma.
- American Academy of Dermatology evidence-based guideline development process: Responding to new challenges and establishing transparency.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of Psoriasis and psoriatic arthritis: Case-b...
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of Psoriasis with phototherapy and photoche...
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of Psoriasis with traditiona...
- Sinecatechins, a defined green tea extract, in the treatment of external anogenital Warts: a randomized controlled trial.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 1. Overview of Psoriasis and guidelines of care for the treatment of Psoriasis with...
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an empha...
- A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential.
- A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
- Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials.
- In vitro correlates of Cell-mediated immunity in human tonsils after natural or induced Rubella virus infection.
- Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital Warts.
- Cytomegalovirus Infection with acute myelocytic leukemia; antiviral (interferon and antibody) responses.
- How should zoster trials be conducted?
- An interactive, computer-based program to educate patients about genital herpes.
- Genital Warts and their treatment.
- External genital Warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts.
- Patient-applied treatment for external genital Warts: the time has come.
- Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
- Imiquimod, a patient-applied immune-response modifier for treatment of external genital Warts.
- Treatment of genital Warts with an immune-response modifier (imiquimod).
- Therapeutic approaches to genital Warts.
- Human papillomavirus and human disease.
- Podophyllotoxin in the treatment of genital Warts.
- Human papilloma virus Infection of the vulva.
- Clinical management of herpes zoster in the elderly patient.
- Hepatitis B Infection in health care personnel of an institution for mentally handicapped children and adults.
- Hepatitis B surface antigen-specific Cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.
- Strain-specific local and systemic Cell-mediated immune responses to cytomegalovirus in humans.
- Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
- Serum immunoconglutinin titers during acute and chronic hepatitis B virus Infection.
- Hemagglutinin and neuraminidase specific Cell-mediated immune responses to influenza A virus following immunization in guinea pigs.
- Halo scalp ring associated with caput succedaneum.
- Failure of recommended treatment for secondary syphilis.
- Patient-applied podofilox for treatment of genital Warts.
- Neutrophilic eccrine Hidradenitis associated with Hodgkin's disease and chemotherapy. A case report.
- Topical podofilox for the treatment of condylomata acuminata in women.
- Current status of podophyllotoxin for the treatment of genital Warts.
- Bridging the gap. Notes of a Wart watcher.
- Rational use of acyclovir in the treatment of mucocutaneous herpes simplex virus and variCella zoster virus infections.
- Distribution and characteristics of hepatitis B surface antigen in body fluids of institutionalized children and adults.
- Hepatitis B e antigen and antibody activity in hepatitis B virus Infection.
- Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
- Studies on defined immunofluorescence in clinical immunopathology. I. Comparisons of chessboard titrations with IgG polymer particles and with indirect immunofluoresce...
- Vaccination by non-parenteral routes: characteristics of immune response.
- Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
- Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
- Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
- Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.
- Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural Infection.
- Host defense mechanisms in viral respiratory Infections.
- Polyphenon E: a new treatment for external anogenital Warts.
- [Imiquimod--clinical efficacy].
- Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
- Nongenital human papillomavirus Infections.
- Therapeutic response of Basal cell carcinoma to the immune response modifier imiquimod 5% cream.
- Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
- External genital Warts: diagnosis, treatment, and prevention.
- Validity of self-reporting of episodes of external genital Warts.
- An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque Psoriasis.
- Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
- Therapy of other viral Infections: herpes to hepatitis.
- Estimating uncertainty in brain region delineations.
- Emerging therapies for herpes viral Infections (types 1 - 8).
- Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
- A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent...
- Recent progress on the topical therapy of onychomycosis.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of Psoriasis with topical th...
Schools
University At Buffalo State University Of New York School Of Medicine
Strong Mem Hsp University Rochester
UCLA Med Center
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- Excision of Malignant Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
University of Rochester -
UCLA Medical Center -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Sutter Solano Medical Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1649217936 | |
| NPPES Provider LastName | BEUTNER | |
| NPPES Provider FirstName | KARL | |
| NPPES Provider ZIPCode | 945349647 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 257.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649217936 |
| Last Name Of The Provider | BEUTNER |
| First Name Of The Provider | KARL |
| View All |
Similar Doctors
|
|
Dr. Serena Mraz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric S. Swann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip Charney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen M. Crowley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin S. Gray, MD |
|
|
Dr. Onaopemipo O. Ofodile, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jacquiline R. Jamora |